[1]
TrungN.D., CuongN.T., BinhN.T., ThuN.T., NamD.V., TamN.C., KhanhL.N., ChinhD.T., NgaN.T. and NamH. 2024. Outcome of using antithymocyte globulin (ATG) induction for low immune risk kidney transplant recipients. Tạp chí Y Dược lâm sàng 108. 19, 2 (Feb. 2024). DOI:https://doi.org/10.52389/ydls.v19i2.2194.